<?xml version='1.0' encoding='utf-8'?>
<document id="16006492"><sentence text="A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters." /><sentence text="A clinical drug-drug interaction between famotidine (a H2 receptor antagonist) and probenecid has not been reproduced in rats"><entity charOffset="41-51" id="DDI-PubMed.16006492.s2.e0" text="famotidine" /><entity charOffset="83-93" id="DDI-PubMed.16006492.s2.e1" text="probenecid" /><pair ddi="false" e1="DDI-PubMed.16006492.s2.e0" e2="DDI-PubMed.16006492.s2.e0" /><pair ddi="false" e1="DDI-PubMed.16006492.s2.e0" e2="DDI-PubMed.16006492.s2.e1" /></sentence><sentence text=" The present study hypothesized that the species-dependent probenecid sensitivity is due to a species difference in the contribution of renal organic anion and cation transporters"><entity charOffset="59-69" id="DDI-PubMed.16006492.s3.e0" text="probenecid" /></sentence><sentence text=" The transport activities of the H2 receptor antagonists (cimetidine, famotidine, and ranitidine) by rat and human basolateral organic anion and cation transporters [human organic anion transporter (hOAT) 1, hOAT2, r/hOAT3, rat organic cation transporter (rOct) 1, and r/hOCT2] were compared using their cDNA transfectants"><entity charOffset="58-68" id="DDI-PubMed.16006492.s4.e0" text="cimetidine" /><entity charOffset="70-80" id="DDI-PubMed.16006492.s4.e1" text="famotidine" /><entity charOffset="86-96" id="DDI-PubMed.16006492.s4.e2" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.16006492.s4.e0" e2="DDI-PubMed.16006492.s4.e0" /><pair ddi="false" e1="DDI-PubMed.16006492.s4.e0" e2="DDI-PubMed.16006492.s4.e1" /><pair ddi="false" e1="DDI-PubMed.16006492.s4.e0" e2="DDI-PubMed.16006492.s4.e2" /><pair ddi="false" e1="DDI-PubMed.16006492.s4.e1" e2="DDI-PubMed.16006492.s4.e1" /><pair ddi="false" e1="DDI-PubMed.16006492.s4.e1" e2="DDI-PubMed.16006492.s4.e2" /></sentence><sentence text=" The transport activities (Vmax/Km) of famotidine (Km, 345 microM) by rOat3 were 8- and 15-fold lower than those of cimetidine (Km, 91 microM) and ranitidine (Km, 155 microM), respectively, whereas the activity by hOAT3 (Km, 124 microM) was 3-fold lower than that of cimetidine (Km, 149 microM) but similar to that of ranitidine (Km, 234 microM)"><entity charOffset="39-49" id="DDI-PubMed.16006492.s5.e0" text="famotidine" /><entity charOffset="116-126" id="DDI-PubMed.16006492.s5.e1" text="cimetidine" /><entity charOffset="147-157" id="DDI-PubMed.16006492.s5.e2" text="ranitidine" /><entity charOffset="267-277" id="DDI-PubMed.16006492.s5.e3" text="cimetidine" /><entity charOffset="318-328" id="DDI-PubMed.16006492.s5.e4" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e0" e2="DDI-PubMed.16006492.s5.e0" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e0" e2="DDI-PubMed.16006492.s5.e1" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e0" e2="DDI-PubMed.16006492.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e0" e2="DDI-PubMed.16006492.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e0" e2="DDI-PubMed.16006492.s5.e4" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e1" e2="DDI-PubMed.16006492.s5.e1" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e1" e2="DDI-PubMed.16006492.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e1" e2="DDI-PubMed.16006492.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e1" e2="DDI-PubMed.16006492.s5.e4" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e2" e2="DDI-PubMed.16006492.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e2" e2="DDI-PubMed.16006492.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e2" e2="DDI-PubMed.16006492.s5.e4" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e3" e2="DDI-PubMed.16006492.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16006492.s5.e3" e2="DDI-PubMed.16006492.s5.e4" /></sentence><sentence text=" Comparison of the relative transport activity with regard to that of cimetidine suggests that famotidine was more efficiently transported by hOAT3 than rOat3, and vice versa, for ranitidine"><entity charOffset="70-80" id="DDI-PubMed.16006492.s6.e0" text="cimetidine" /><entity charOffset="95-105" id="DDI-PubMed.16006492.s6.e1" text="famotidine" /><entity charOffset="180-190" id="DDI-PubMed.16006492.s6.e2" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.16006492.s6.e0" e2="DDI-PubMed.16006492.s6.e0" /><pair ddi="false" e1="DDI-PubMed.16006492.s6.e0" e2="DDI-PubMed.16006492.s6.e1" /><pair ddi="false" e1="DDI-PubMed.16006492.s6.e0" e2="DDI-PubMed.16006492.s6.e2" /><pair ddi="false" e1="DDI-PubMed.16006492.s6.e1" e2="DDI-PubMed.16006492.s6.e1" /><pair ddi="false" e1="DDI-PubMed.16006492.s6.e1" e2="DDI-PubMed.16006492.s6.e2" /></sentence><sentence text=" Only ranitidine was efficiently transported by hOAT2 (Km, 396 microM)"><entity charOffset="6-16" id="DDI-PubMed.16006492.s7.e0" text="ranitidine" /></sentence><sentence text=" rOct1 accepts all of the H2 receptor antagonists with a similar activity, whereas the transport activities of ranitidine and famotidine (Km, 61/56 microM) by r/hOCT2 were markedly lower than that of cimetidine (Km, 69/73 microM)"><entity charOffset="111-121" id="DDI-PubMed.16006492.s8.e0" text="ranitidine" /><entity charOffset="126-136" id="DDI-PubMed.16006492.s8.e1" text="famotidine" /><entity charOffset="200-210" id="DDI-PubMed.16006492.s8.e2" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.16006492.s8.e0" e2="DDI-PubMed.16006492.s8.e0" /><pair ddi="false" e1="DDI-PubMed.16006492.s8.e0" e2="DDI-PubMed.16006492.s8.e1" /><pair ddi="false" e1="DDI-PubMed.16006492.s8.e0" e2="DDI-PubMed.16006492.s8.e2" /><pair ddi="false" e1="DDI-PubMed.16006492.s8.e1" e2="DDI-PubMed.16006492.s8.e1" /><pair ddi="false" e1="DDI-PubMed.16006492.s8.e1" e2="DDI-PubMed.16006492.s8.e2" /></sentence><sentence text=" Probenecid was a potent inhibitor of r/OAT3 (Ki, 2"><entity charOffset="1-11" id="DDI-PubMed.16006492.s9.e0" text="Probenecid" /></sentence><sentence text="6-5" /><sentence text="8 microM), whereas it did not interact with OCTs" /><sentence text=" These results suggest that, in addition to the absence of OCT1 in human kidney, a species difference in the transport activity by hOAT3 and rOat3 accounts, at least in part, for the species difference in the drug-drug interaction between famotidine and probenecid"><entity charOffset="239-249" id="DDI-PubMed.16006492.s12.e0" text="famotidine" /><entity charOffset="254-264" id="DDI-PubMed.16006492.s12.e1" text="probenecid" /><pair ddi="false" e1="DDI-PubMed.16006492.s12.e0" e2="DDI-PubMed.16006492.s12.e0" /><pair ddi="false" e1="DDI-PubMed.16006492.s12.e0" e2="DDI-PubMed.16006492.s12.e1" /></sentence><sentence text="" /></document>